BONUS CAP-ZERTIFIKAT - ROCHE GS Stock

Certificat

DE000VM75W94

Market Closed - Boerse Frankfurt Warrants 14:04:37 2024-05-17 EDT
288.4 EUR +0.36% Intraday chart for BONUS CAP-ZERTIFIKAT - ROCHE GS
Current month+4.66%
1 month+5.48%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-17 288.4 +0.36%
24-05-16 287.4 +1.65%
24-05-15 282.7 +1.12%
24-05-14 279.6 -1.01%
24-05-13 282.4 +0.17%

Real-time Boerse Frankfurt Warrants

Last update May 17, 2024 at 02:04 pm

More quotes

Static data

Product typeCertificats Bonus
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
WKN VM75W9
ISINDE000VM75W94
Date issued 2024-01-08
Strike 300 CHF
Maturity 2024-12-20 (216 Days)
Parity 1 : 1
Emission price 303.2
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 302.4
Lowest since issue 265.8
Spread 3.14
Spread %1.08%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
237.1 CHF
Average target price
279.4 CHF
Spread / Average Target
+17.84%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW